Skip to main content
SpringerLink
Log in

A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

Matrix metalloproteinase-9 (MMP-9, gelatinase B) plays a key role in cancer invasion and metastasis by degradating the extracellular matrix (ECM) and basement membrane barriers. A cytosine (C)-thymidine (T) single nucleotide polymorphism (SNP) at position –1562 in the MMP-9 promoter is reported to affect expression of this gene. The purpose of this study was to investigate the relation between the –1562 C/T polymorphism and the development and progression of gastric cancer.

Methods

The study population included 177 gastric cancer patients and 224 healthy control subjects. The SNP in the MMP-9 promoter was analyzed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and sequencing. Genotype frequencies were compared between patients and controls, and the association of genotypes with clinicopathological features was studied.

Results

Genotype frequencies in gastric cancer patients were similar to those in control subjects (P = 0.223). However, significant association was found between degree of tumor invasion, clinical stage, and lymphatic invasion and the MMP-9 polymorphism in gastric cancer patients (P<0.05, for each).

Conclusions

Our results indicate that the T allele in the MMP-9 promoter is associated with the invasive phenotype of gastric cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

MMP-9:

Matrix metalloproteinase-9

SNP:

Single nucleotide polymorphism

C:

Cytosine

T:

Thymidine

RFLP:

Restriction fragment length polymorphism

ECM:

Extracellular matrix

PCR:

Polymerase chain reaction

OR:

Odds ratio

CI:

Confidence interval

References

  • Baker EA, Leaper DJ (2003) The plasminogen activator and matrix metalloproteinase systems in colorectal cancer: relationship to tumour pathology. Eur J Cancer 39:981–988

    Article  CAS  PubMed  Google Scholar 

  • Behrens P, Rothe M, Wellmann A, Krischler J, Wernert N (2001) The Ets-1 transcription factor is up-regulated together with MMP-1 and MMP-9 in the stroma of pre-invasive breast cancer. J Pathol 194:43–50

    Article  CAS  PubMed  Google Scholar 

  • Chicoine E, Esteve PO, Robledo O, Van Themsche C, Potworowski EF, St-Pierre Y (2002) Evidence for the role of promoter methylation in the regulation of MMP-9 gene expression. Biochem Biophys Res Commun 297:765–772

    Article  CAS  PubMed  Google Scholar 

  • Ferrand PE, Parry S, Sammel M, Macones GA, Kuivaniemi H, Romero R, Strauss JF 3rd (2002) A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Mol Hum Reprod 8:494–501

    Article  CAS  PubMed  Google Scholar 

  • Forget MA, Desrosiers RR, Beliveau R (1999) Physiological roles of matrix metalloproteinases; implications for tumor growth and metastasis. Can J Physiol Pharmacol 77:465–480

    Article  CAS  PubMed  Google Scholar 

  • Gum R, Lengyel E, Juarez J, Chen JH, Sato H, Seiki M, Boyd D (1996) Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J Biol Chem 271:10672–10680

    Article  CAS  PubMed  Google Scholar 

  • Hujanen ES, Vaisanen A, Zheng A, Tryggvason K, Turpeenniemi-Hujanen T (1994) Modulation of M(r) 72,000 and M(r) 92,000 type-IV collagenase (gelatinase A and B) gene expression by interferons alpha and gamma in human melanoma. Int J Cancer 58:582–586

    CAS  PubMed  Google Scholar 

  • Japanese Gastric Cancer Association (1998) Japanese classification of gastric carcinoma. 2nd English Edition. Gastric Cancer 1:10–24

    Article  PubMed  Google Scholar 

  • Jones JL, Glynn P, Walker RA (1999) Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas. J Pathol 189:161–168

    Article  CAS  PubMed  Google Scholar 

  • Kallakury BV, Karikehalli S, Haholu A, Sheehan CE, Azumi N, Ross JS (2001) Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma. Clin Cancer Res 7:3113–3119

    CAS  PubMed  Google Scholar 

  • Kohn EC, Liotta LA (1995) Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 55:1856–1862

    CAS  PubMed  Google Scholar 

  • Kuraoka K, Matsumura S, Hamai Y, Nakachi K, Imai K, Matsusaki K, Oue N, Ito R, Nakayama H, Yasui W (2003) A single nucleotide polymorphism in the transmenbrane domain coding region of HER-2 is associated with development and malignant phenotype of gastric cancer. Int J Cancer 107:593–596

    Article  CAS  PubMed  Google Scholar 

  • Lauren P (1965) The two histological main types of gastric carcinoma. Diffuse and so-called intestinal type carcinoma: an attempt at histological classification. Acta Pathol Microbiol Scand 64:31–49

    CAS  PubMed  Google Scholar 

  • Liotta LA, Steeg PS, Stetler-Stevenson WG (1991) Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64:327–336

    Article  CAS  PubMed  Google Scholar 

  • Matsumura S, Oue N, Kitadai Y, Chayama K, Yoshida K, Yamaguchi Y, Toge T, Imai K, Nakachi K, Yasui W (2004) A single nucleotide polymorphism in the MMP-1 promoter is correlated with histological differentiation of gastric cancer. J Cancer Res Clin Oncol 130:259–265

    Article  CAS  Google Scholar 

  • McDonnell S, Matrisian LM (1990) Stromelysin in tumor progression and metastasis. Cancer Metastasis Rev 9:305–319

    CAS  PubMed  Google Scholar 

  • Murray GI, Duncan ME, Arbuckle E, Melvin WT, Fothergill JE (1998) Matrix metalloproteinases and their inhibitors in gastric cancer. Gut 43:791–797

    CAS  PubMed  Google Scholar 

  • Nakayama T, Ito M, Ohtsuru A, Naito S, Nakashima M, Fagin JA, Yamashita S, Sekine I (1996) Expression of the Ets-1 proto-oncogene in human gastric carcinoma: correlation with tumor invasion. Am J Pathol 149:1931–1939

    CAS  PubMed  Google Scholar 

  • Nagase H, Woessner JF Jr (1999) Matrix metalloproteinases. J Biol Chem 274:21491–494

    Article  CAS  PubMed  Google Scholar 

  • Oue N, Motoshita J, Yokozaki H, Hayashi K, Tahara E, Taniyama K, Matsusaki K, Yasui W (2002) Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-ß in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas. J Pathol 198:55–59

    Article  CAS  PubMed  Google Scholar 

  • Oue N, Oshimo Y, Nakayama H, Ito R, Yoshida K, Matsusaki K, Yasui W (2003) DNA methylation of multiple genes in gastric carcinoma: association with histological type and CpG island methylator phenotype. Cancer Sci 94:901–905

    CAS  PubMed  Google Scholar 

  • Ozalp S, Tanir HM, Yalcin OT, Kabukcuoglu S, Oner U, Uray M (2003) Prognostic value of matrix metalloproteinase-9 (gelatinase-B) expression in epithelial ovarian tumors. Eur J Gynaecol Oncol 24:417–420

    CAS  PubMed  Google Scholar 

  • Park CC, Bissell MJ, Barcellos-Hoff MH (2000) The influence of the microenvironment on the malignant phenotype. Mol Med Today 6:324–329

    Article  CAS  PubMed  Google Scholar 

  • Rao JS, Steck PA, Mohanam S, Stetler-Stevenson WG, Liotta LA, Sawaya R (1993) Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors. Cancer Res 53:2208–2211

    CAS  PubMed  Google Scholar 

  • Sakata K, Satoh M, Someya M, Asanuma H, Nagakura H, Oouchi A, Nakata K, Kogawa K, Koito K, Hareyama M, Himi T (2004) Expression of matrix metalloproteinase 9 is a prognostic factor in patients with non-Hodgkin lymphoma. Cancer 100:356–365

    Article  CAS  PubMed  Google Scholar 

  • Sehgal I, Baley PA, Thompson TC (1996) Transforming growth factor beta1 stimulates contrasting responses in metastatic versus primary mouse prostate cancer-derived cell lines in vitro. Cancer Res 56:3359–3365

    CAS  PubMed  Google Scholar 

  • Sobin LH, Wittekind CH (eds) (2002) TNM classification of malignant tumors, 6th edn. Wiley-Liss, New York, pp 65–68

  • Tanioka Y, Yoshida T, Yagawa T, Saiki Y, Takeo S, Harada T, Okazawa T, Yanai H, Okita K (2003) Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer. Br J Cancer 89:2116–2121

    Article  CAS  PubMed  Google Scholar 

  • Wroblewski LE, Pritchard DM, Carter S, Varro A (2002) Gastrin-stimulated gastric epithelial cell invasion: the role and mechanism of increased matrix metalloproteinase 9 expression. Biochem J 365:873–879

    CAS  PubMed  Google Scholar 

  • Yasui W, Yokozaki H, Fujimoto J, Naka K, Kuniyasu H, Tahara E (2000) Genetic and epigenetic alterations in multistep carcinogenesis of the stomach. J Gastroenterol 35:111–115

    CAS  PubMed  Google Scholar 

  • Zhang B, Ye S, Hermann SM, Eriksson P, de Maat M, Evans A, Arveiler D, Luc G, Cambien F, Hamsten A, Watkins H, Henney AM (1999) Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99:1788–794

    CAS  PubMed  Google Scholar 

  • Zhang S, Li L, Lin JY, Lin H (2003) Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma. World J Gastroenterol 9:899–904

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Masayoshi Takatani and Mutsumi Ueda, Department of Molecular Pathology, Hiroshima University Graduate School of Biomedical Sciences, for their excellent technical assistance and advice

Author information

Authors and Affiliations

  1. Department of Molecular Pathology, Hiroshima University Graduate School of Biomedical Sciences, 1-2-3 Kasumi, Minami-ku, 734-8551, Hiroshima, Japan

    Shunji Matsumura, Naohide Oue, Hirofumi Nakayama & Wataru Yasui

  2. Department of Medicine and Molecular Science, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan

    Yasuhiko Kitadai & Kazuaki Chayama

  3. Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan

    Kazuhiro Yoshida & Yoshiyuki Yamaguchi

  4. Department of Radiobiology/Molecular Epidemiology, Radiation Effects Research Foundation, Hiroshima, Japan

    Kazue Imai & Kei Nakachi

  5. Department of Surgery, Hofu Institute of Gastroenterology, Yamaguchi, Japan

    Keisuke Matsusaki

Authors
  1. Shunji Matsumura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naohide Oue
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hirofumi Nakayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yasuhiko Kitadai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kazuhiro Yoshida
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yoshiyuki Yamaguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kazue Imai
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kei Nakachi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Keisuke Matsusaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Kazuaki Chayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Wataru Yasui
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wataru Yasui.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matsumura, S., Oue, N., Nakayama, H. et al. A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer. J Cancer Res Clin Oncol 131, 19–25 (2005). https://doi.org/10.1007/s00432-004-0621-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-004-0621-4

Keywords

Search

Navigation